JNJ Johnson & Johnson

  1. Stocks
  2. Healthcare
  3. NYSE: JNJ

Price (delayed)

$154.35

Market cap

$401.11B

P/E Ratio

31.89

Dividend/share

$4.58

EPS

$4.84

Enterprise value

$427.16B

Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones ...

Highlights
JNJ's price to earnings (P/E) is 30% lower than its 5-year quarterly average of 45.5 but 20% higher than its last 4 quarters average of 26.5
The quick ratio has decreased by 24% YoY but it has increased by 14% QoQ
Johnson & Johnson's debt has soared by 60% YoY and by 33% from the previous quarter
Johnson & Johnson's net income has decreased by 36% YoY and by 29% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: https://www.jnj.com/
Peers: PFE MRK SYK MDT

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.6B
Market cap
$401.11B
Enterprise value
$427.16B
Valuations
Price to earnings (P/E)
31.89
Price to book (P/B)
5.67
Price to sales (P/S)
4.18
EV/EBIT
27.37
EV/EBITDA
18.83
EV/Sales
4.44
Earnings
Revenue
$96.26B
EBIT
$15.61B
EBITDA
$22.69B
Free cash flow
$16.21B
Per share
EPS
$4.84
Free cash flow per share
$6.22
Book value per share
$27.21
Revenue per share
$36.95
TBVPS
$39.51
Balance sheet
Total assets
$195.97B
Total liabilities
$125.1B
Debt
$52.91B
Equity
$70.87B
Working capital
$4.02B
Liquidity
Debt to equity
0.75
Current ratio
1.07
Quick ratio
0.81
Net debt/EBITDA
1.15
Margins
EBITDA margin
23.6%
Gross margin
66.9%
Net margin
13.2%
Operating margin
25%
Efficiency
Return on assets
6.9%
Return on equity
17%
Return on invested capital
21.8%
Return on capital employed
11.5%
Return on sales
16.2%
Dividend
Dividend yield
2.97%
DPS
$4.58
Payout ratio
94.6%

JNJ stock price

How has the Johnson & Johnson stock price performed over time
Intraday
-0.04%
1 week
-2.87%
1 month
-5.09%
1 year
-13.99%
YTD
-12.62%
QTD
-0.42%

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$96.26B
Gross profit
$64.38B
Operating income
$24.11B
Net income
$12.72B
Gross margin
66.9%
Net margin
13.2%
Johnson & Johnson's net margin has decreased by 37% YoY and by 30% from the previous quarter
Johnson & Johnson's net income has decreased by 36% YoY and by 29% QoQ
The operating income rose by 7% year-on-year and by 3.1% since the previous quarter
Johnson & Johnson's operating margin has increased by 5% YoY

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
JNJ P/E details
P/E
31.89
P/B
5.67
P/S
4.18
EV/EBIT
27.37
EV/EBITDA
18.83
EV/Sales
4.44
The EPS has contracted by 36% YoY and by 29% from the previous quarter
JNJ's price to earnings (P/E) is 30% lower than its 5-year quarterly average of 45.5 but 20% higher than its last 4 quarters average of 26.5
JNJ's equity is down by 8% since the previous quarter and by 5% year-on-year
JNJ's price to book (P/B) is 6% less than its 5-year quarterly average of 6.0 and 3.9% less than its last 4 quarters average of 5.9
The price to sales (P/S) is 9% less than the 5-year quarterly average of 4.6 and 9% less than the last 4 quarters average of 4.6

Efficiency

How efficient is Johnson & Johnson business performance
The return on assets has declined by 38% year-on-year and by 31% since the previous quarter
The company's return on equity fell by 38% YoY and by 28% QoQ
The ROS has contracted by 30% from the previous quarter and by 28% YoY
Johnson & Johnson's return on invested capital has decreased by 27% QoQ and by 26% YoY

Dividends

What is JNJ's dividend history
Dividend details
DPS
$4.58
Dividend yield
2.97%
Payout ratio
94.6%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 57% greater than its total liabilities
The quick ratio has decreased by 24% YoY but it has increased by 14% QoQ
JNJ's current ratio is down by 23% year-on-year but it is up by 8% since the previous quarter
Johnson & Johnson's debt is 25% less than its equity
The company's debt to equity has surged by 70% YoY and by 44% QoQ
Johnson & Johnson's debt has soared by 60% YoY and by 33% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.